Quek, J
Dye CK, Wu H, VanNoy B, et al
One of the most commonly studied weight-loss drugs, GLP-1RAs, were initially developed to treat T2D by reducing postprandial glucose excursions, augmenting glucose-dependent insulin release, inhibiting glucagon secretion and delaying gastric emptying (136, 137)
These help with nutrient absorption and satisfaction, but keep portions modest since fats can slow digestion further and potentially increase nausea
Semaglutide helps with weight loss by reducing hunger, increasing feelings of fullness, and slowing down how fast the stomach empties
8.1 Nanoparticles affecting NK cells and T cells A variety of nanoparticles have been shown to be able to simultaneously regulate NK cells and T cells to improve anti-tumor immunity, such as the zinc ions released by the nanoclusters of zinc-sulfur@bovine serum albumin in the acidic tumor microenvironment by the self-assembly method can significantly enhance the signal of cyclic guanosine-adenosine monophosphate synthase/interferon gene stimulator (cGAS/STING) thereby promoting the infiltration of CD8 + T cells and the cross-presentation of NK cells at the tumor site, and improving the effectiveness of tumor immunotherapy (191)